JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB24189

Anti-CRM1 antibody

5

(2 Reviews)

|

(27 Publications)

Rabbit Polyclonal CRM1 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 27 publications.

View Alternative Names

CRM1, XPO1, Exportin-1, Exp1, Chromosome region maintenance 1 protein homolog

4 Images
Immunocytochemistry/ Immunofluorescence - Anti-CRM1 antibody (AB24189)
  • ICC/IF

Ap17016****

Immunocytochemistry/ Immunofluorescence - Anti-CRM1 antibody (AB24189)

ICC/IF image of ab24189 stained HeLa cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab24189 at 1μg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- rabbit (ab96899) IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CRM1 antibody (AB24189)
  • IHC-P

Ap16036****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CRM1 antibody (AB24189)

IHC image of CRM1 staining in Human normal hippocampus formalin fixed paraffin embedded tissue section, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab24189, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Western blot - Anti-CRM1 antibody (AB24189)
  • WB

Project1433****

Western blot - Anti-CRM1 antibody (AB24189)

ab24189 detects a band of ~ 100 kDa in HeLa whole and HeLa nuclear cell lysates. This is somewhat smaller than the predicted band size according to Swissprot (123 kDa), however as both these bands are specifically blocked by the addition of the immunizing peptide (ab25749) we believe they represent CRM1.

All lanes:

Western blot - Anti-CRM1 antibody (ab24189) at 1 µg/mL

Lane 1:

HeLa whole cell lysate at 20 µg

Lane 2:

HeLa nuclear lysate at 20 µg

Lane 3:

HeLa whole cell lysate at 20 µg with Human CRM1 peptide (<a href='/en-us/products/unavailable/human-crm1-peptide-ab25749'>ab25749</a>)

Lane 4:

HeLa nuclear cell lysate at 20 µg with Human CRM1 peptide (<a href='/en-us/products/unavailable/human-crm1-peptide-ab25749'>ab25749</a>)

Secondary

All lanes:

Goat polyclonal to Rabbit IgG at 1/10000 dilution

Predicted band size: 123 kDa

Observed band size: 100 kDa

false

This image is courtesy of an anonymous Abreview

Western blot - Anti-CRM1 antibody (AB24189)
  • WB

Ap17016****

Western blot - Anti-CRM1 antibody (AB24189)

This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 3% milk before being incubated with ab24189 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution.

All lanes:

Western blot - Anti-CRM1 antibody (ab24189) at 1 µg/mL

All lanes:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate (ab27252) at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution

Predicted band size: 123 kDa

Observed band size: 120 kDa,73 kDa

true

Exposure time: 90s

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p>Abcam recommends using 3% milk as the blocking agent.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CRM1 also known as exportin 1 is a significant nuclear export protein with a molecular mass of approximately 123 kDa. It is expressed in a wide range of eukaryotic cells being an important component in transporting molecules from the nucleus to the cytoplasm. The CRM1 protein binds cargo proteins bearing a leucine-rich nuclear export signal (NES) and facilitates their passage through the nuclear pore complex. Due to its essential role in nuclear-cytoplasmic transport CRM1 serves as a targeted protein in various research and therapeutic contexts.
Biological function summary

CRM1 participates in the regulation of gene expression by controlling the export of mRNA and ribosomal subunits. It does not act alone but associates with other proteins such as Ran GTPase to form a functioning export complex. This CRM1 complex plays a pivotal role in maintaining cellular homeostasis and responding to cellular stress by regulating the localization of key signaling molecules and transcription factors.

Pathways

CRM1 integrates into critical pathways such as the Wnt signaling pathway and DNA damage response. In the Wnt signaling pathway CRM1 influences the localization and activity of beta-catenin a central protein in the pathway. In the DNA damage response CRM1 interacts with p53 a notable tumor suppressor protein. Through these pathways CRM1 ensures proper control of cell proliferation apoptosis and differentiation.

CRM1 is implicated in cancer and viral infections. Dysregulation of CRM1-mediated nuclear export can lead to abnormal accumulation of oncogenic proteins in the cytoplasm which contributes to cancer pathogenesis. CRM1 overexpression is often observed in several cancers including leukemia and pancreatic cancer linking it to essential regulatory proteins like p53 and NF-kB. Additionally certain viruses exploit CRM1’s export mechanism to enhance their replication making it a target for antiviral research.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Mediates the nuclear export of cellular proteins (cargos) bearing a leucine-rich nuclear export signal (NES) and of RNAs. In the nucleus, in association with RANBP3, binds cooperatively to the NES on its target protein and to the GTPase RAN in its active GTP-bound form (Ran-GTP). Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, disassembling of the complex and hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause release of the cargo from the export receptor. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Involved in U3 snoRNA transport from Cajal bodies to nucleoli. Binds to late precursor U3 snoRNA bearing a TMG cap.. (Microbial infection) Mediates the export of unspliced or incompletely spliced RNAs out of the nucleus from different viruses including HIV-1, HTLV-1 and influenza A. Interacts with, and mediates the nuclear export of HIV-1 Rev and HTLV-1 Rex proteins. Involved in HTLV-1 Rex multimerization.
See full target information XPO1

Publications (27)

Recent publications for all applications. Explore the full list and refine your search

PLoS pathogens 21:e1013184 PubMed40367285

2025

Virus and cell specific HMGB1 secretion and subepithelial infiltrate formation in adenovirus keratitis.

Applications

Unspecified application

Species

Unspecified reactive species

Amrita Saha,Mohammad Mirazul Islam,Rahul Kumar,Ashrafali Mohamed Ismail,Emanuel Garcia,Rama R Gullapali,James Chodosh,Jaya Rajaiya

Experimental and therapeutic medicine 26:326 PubMed37346402

2023

Selective nuclear export inhibitor KPT‑330 enhances the radiosensitivity of esophageal carcinoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Xu,Shan Wu,Guang Li

Frontiers in cell and developmental biology 10:1070599 PubMed36568985

2022

G2/M checkpoint regulation and apoptosis facilitate the nuclear egress of parvoviral capsids.

Applications

Unspecified application

Species

Unspecified reactive species

Salla Mattola,Elina Mäntylä,Vesa Aho,Sami Salminen,Simon Leclerc,Mikko Oittinen,Kari Salokas,Jani Järvensivu,Satu Hakanen,Teemu O Ihalainen,Keijo Viiri,Maija Vihinen-Ranta

Frontiers in oncology 12:927751 PubMed36387125

2022

Down-regulated expression of CDK5RAP3 and UFM1 suggests a poor prognosis in gastric cancer patients.

Applications

Unspecified application

Species

Unspecified reactive species

Mi Lin,Ning-Zi Lian,Long-Long Cao,Chang-Ming Huang,Chao-Hui Zheng,Ping Li,Jian-Wei Xie,Jia-Bin Wang,Jun Lu,Qi-Yue Chen,Ya-Han Li,Zhu-Huai Peng,Xiao-Yu Zhang,Yi-Xian Mei,Jian-Xian Lin

Med (New York, N.Y.) 3:774-791.e7 PubMed36195086

2022

Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Diego F Coutinho,Prabhjot S Mundi,Lianna J Marks,Chelsey Burke,Michael V Ortiz,Daniel Diolaiti,Lauren Bird,Kelly L Vallance,Glorymar Ibáñez,Daoqi You,Matthew Long,Nestor Rosales,Adina Grunn,Andoyo Ndengu,Armaan Siddiquee,Ervin S Gaviria,Allison R Rainey,Ladan Fazlollahi,Hajime Hosoi,Andrea Califano,Andrew L Kung,Filemon S Dela Cruz

PLoS pathogens 18:e1010588 PubMed35709296

2022

RANBP2 and USP9x regulate nuclear import of adenovirus minor coat protein IIIa.

Applications

Unspecified application

Species

Unspecified reactive species

Ashrafali M Ismail,Amrita Saha,Ji S Lee,David F Painter,Yinghua Chen,Gurdeep Singh,Gabriela N Condezo,James Chodosh,Carmen San Martín,Jaya Rajaiya

Bioengineered 13:624-633 PubMed34898375

2021

The abnormal expression of chromosomal region maintenance 1 (CRM1)-survivin axis in ovarian cancer and its related mechanisms regulating proliferation and apoptosis of ovarian cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Zhang,Xinyan Xu,Yongfeng Chen,Xiaoju Guan,Hong Zhu,Yuhong Qi

Molecular cancer therapeutics 20:2352-2361 PubMed34583979

2021

Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models.

Applications

Unspecified application

Species

Unspecified reactive species

Katelyn F Handley,Cristian Rodriguez-Aguayo,Shaolin Ma,Elaine Stur,Robiya Joseph,Emine Bayraktar,Santosh K Dasari,Nghi Nguyen,Reid T Powell,Mary Sobieski,Cristina Ivan,Mark Kim,Sujanitha Umamaheswaran,Deanna Glassman,Yunfei Wen,Paola Amero,Clifford Stephan,Robert L Coleman,Yosef Landesman,Shannon N Westin,Prahlad T Ram,Anil K Sood

Pharmaceuticals (Basel, Switzerland) 14: PubMed34072442

2021

miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Silvia Martini,Valentina Zuco,Monica Tortoreto,Stefano Percio,Elisa Campi,Rihan El Bezawy,Valentina Doldi,Yosef Landesman,Marzia Pennati,Nadia Zaffaroni

Journal of cell science 134: PubMed33912945

2021

On the asymmetric partitioning of nucleocytoplasmic transport - recent insights and open questions.

Applications

Unspecified application

Species

Unspecified reactive species

Joanna Kalita,Larisa E Kapinos,Roderick Y H Lim
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com